Announce Date | 02/12/2025 |
EPS Normalized Actual | $0.2 (Beat by $0.05) |
EPS GAAP Actual | $0.2 (Beat by $0.05) |
Revenue Actual | $0.229684B |
Revenue Surprise | Beat by $229.684M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 1.93 | 13.98 | 1.83292 | 2.0575 | 1 |
Dec 2028 | 2.41 | 11.2 | 2.24755 | 2.54431 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.17 | 0.17 | 0.229684B | 14.13% | 229.68M |
FQ3 2024 (Sep 2024) | 0.17 | 0.17 | 0.234742B | -3.31% | 234.74M |
FQ2 2024 (Jun 2024) | 0.21 | 0.21 | 0.239292B | 15.95% | 239.29M |
FQ1 2024 (Mar 2024) | 0.07 | 0.07 | 0.210797B | 100% | 210.8M |
FQ4 2023 (Oct 2023) | 0.11 | 0.11 | 0.197241B | -6.28% | 197.24M |
FQ3 2023 (Jul 2023) | 0.33 | 0.33 | 0.242512B | -13.24% | 242.51M |
FQ2 2023 (Apr 2023) | 0 | 0 | 0.201124B | 100% | 201.12M |
FQ4 2022 (Oct 2022) | 0.2 | 0.2 | 0.209622B | 100% | 209.62M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0 | -- | 0 | 0 | 4 |
FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 4 |
FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 4 |
FQ4 2026 (Oct 2026) | 0.42749 | -- | 0.42749 | 0.42749 | 4 |
FQ3 2026 (Jul 2026) | 0.44343 | -- | 0.44343 | 0.44343 | 4 |
FQ2 2026 (Jun 2026) | 0.325 | -- | 0.30961 | 0.34301 | 2 |
FQ1 2026 (Mar 2026) | 0.21 | -- | 0.20005 | 0.22164 | 3 |
FQ4 2025 (Dec 2025) | 0.26393 | 35.59 | 0.25143 | 0.27856 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.29B | -- | 0.29B | 0.3B | 5 |
FQ2 2027 (Jun 2027) | 0.3B | -- | 0.3B | 0.31B | 5 |
FQ1 2027 (Mar 2027) | 0.26B | -- | 0.26B | 0.27B | 5 |
FQ4 2026 (Oct 2026) | 0.32B | -- | 0.32B | 0.32B | 4 |
FQ3 2026 (Jul 2026) | 0.32B | -- | 0.32B | 0.32B | 6 |
FQ2 2026 (Jun 2026) | 0.29B | -- | 0.28B | 0.31B | 3 |
FQ1 2026 (Mar 2026) | 0.26B | -- | 0.25B | 0.27B | 4 |
FQ4 2025 (Dec 2025) | 0.25B | 9.14 | 0.24B | 0.26B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.17 | 0.17 | 100% | |
FQ3 2024 (Sep 2024) | 0.17 | 0.17 | 100% | |
FQ2 2024 (Jun 2024) | 0.21 | 0.21 | 100% | |
FQ1 2024 (Mar 2024) | 0.07 | 0.07 | 100% | |
FQ4 2023 (Oct 2023) | 0.11 | 0.11 | 100% | |
FQ3 2023 (Jul 2023) | 0.33 | 0.33 | 100% | |
FQ2 2023 (Apr 2023) | 0 | 0 | NAN% | |
FQ4 2022 (Oct 2022) | 0.2 | 0.2 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $0.23B | $229.68M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.23B | $234.74M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.24B | $239.29M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.21B | $210.8M | 100% |
FQ4 2023 (Oct 2023) | $0B | $0.2B | $197.24M | 100% |
FQ3 2023 (Jul 2023) | $0B | $0.24B | $242.51M | 100% |
FQ2 2023 (Apr 2023) | $0B | $0.2B | $201.12M | 100% |
FQ4 2022 (Oct 2022) | $0B | $0.21B | $209.62M | 100% |